35804859|t|Haloperidol Instigates Endometrial Carcinogenesis and Cancer Progression by the NF-kappaB/CSF-1 Signaling Cascade.
35804859|a|Haloperidol is a routine drug for schizophrenia and palliative care of cancer; it also has antitumor effects in several types of cancer. However, the role of haloperidol in endometrial cancer (EC) development is still unclear. Here, we show that chronic haloperidol treatment in clinically relevant doses induced endometrial hyperplasia in normal mice and promoted tumor growth and malignancy in mice with orthotopic EC. The pharmacokinetic study indicated that haloperidol highly accumulated in the uterus of mice. In vitro studies revealed that haloperidol stimulated the cellular transformation of human endometrial epithelial cells (HECCs) and promoted the proliferation, migration, and invasion of human endometrial carcinoma cells (HECCs) by activating nuclear factor kappa B (NF-kappaB) and its downstream signaling target, colony-stimulating factor 1 (CSF-1). Gain of function of CSF-1 promotes the cellular transformation of HEECs and the malignant progression of HECCs. Moreover, blockade of CSF-1 inhibited haloperidol-promoted EC progression in vitro and in vivo. A population-based cohort study of EC patients further demonstrated that the use of haloperidol was associated with increased EC-specific mortality. Collectively, these findings indicate that clinical use of haloperidol could potentially be harmful to female patients with EC.
35804859	0	11	Haloperidol	Chemical	MESH:D006220
35804859	23	49	Endometrial Carcinogenesis	Disease	MESH:D063646
35804859	54	60	Cancer	Disease	MESH:D009369
35804859	80	89	NF-kappaB	Gene	4790
35804859	90	95	CSF-1	Gene	1435
35804859	115	126	Haloperidol	Chemical	MESH:D006220
35804859	149	162	schizophrenia	Disease	MESH:D012559
35804859	186	192	cancer	Disease	MESH:D009369
35804859	244	250	cancer	Disease	MESH:D009369
35804859	273	284	haloperidol	Chemical	MESH:D006220
35804859	288	306	endometrial cancer	Disease	MESH:D016889
35804859	308	310	EC	Disease	MESH:D016889
35804859	369	380	haloperidol	Chemical	MESH:D006220
35804859	428	451	endometrial hyperplasia	Disease	MESH:D004714
35804859	462	466	mice	Species	10090
35804859	480	485	tumor	Disease	MESH:D009369
35804859	497	507	malignancy	Disease	MESH:D009369
35804859	511	515	mice	Species	10090
35804859	532	534	EC	Disease	MESH:D016889
35804859	577	588	haloperidol	Chemical	MESH:D006220
35804859	625	629	mice	Species	10090
35804859	662	673	haloperidol	Chemical	MESH:D006220
35804859	716	721	human	Species	9606
35804859	818	823	human	Species	9606
35804859	824	845	endometrial carcinoma	Disease	MESH:D016889
35804859	874	896	nuclear factor kappa B	Gene	4790
35804859	898	907	NF-kappaB	Gene	4790
35804859	946	973	colony-stimulating factor 1	Gene	1435
35804859	975	980	CSF-1	Gene	1435
35804859	1003	1008	CSF-1	Gene	1435
35804859	1117	1122	CSF-1	Gene	1435
35804859	1133	1144	haloperidol	Chemical	MESH:D006220
35804859	1154	1156	EC	Disease	MESH:D016889
35804859	1226	1228	EC	Disease	MESH:D016889
35804859	1229	1237	patients	Species	9606
35804859	1275	1286	haloperidol	Chemical	MESH:D006220
35804859	1317	1319	EC	Disease	MESH:D016889
35804859	1399	1410	haloperidol	Chemical	MESH:D006220
35804859	1450	1458	patients	Species	9606
35804859	1464	1466	EC	Disease	MESH:D016889
35804859	Association	MESH:D016889	1435
35804859	Positive_Correlation	MESH:D006220	MESH:D004714
35804859	Positive_Correlation	MESH:D006220	MESH:D009369
35804859	Association	MESH:D006220	1435
35804859	Association	MESH:D009369	1435
35804859	Association	MESH:D016889	4790
35804859	Positive_Correlation	MESH:D006220	4790
35804859	Positive_Correlation	MESH:D006220	MESH:D016889
35804859	Negative_Correlation	MESH:D006220	MESH:D012559
35804859	Positive_Correlation	MESH:D006220	MESH:D063646

